Global Biologics Safety Testing Market – Analysis By Product, Test, Application, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)
EXECUTIVE SUMMARY
Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing number of drug launches, high incidence and large economic burden of chronic diseases. In the coming years, emerging markets and increasing pharmaceutical outsourcing are expected to offer growth opportunities for players in the biologics safety testing market. The rising need for biologics has resulted in unprecedented growth in the number of biopharmaceutical companies. Increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve aspects of manufacturing processes such as productivity and cost-efficiency.
High kits and reagents accounted for the largest share of the market among product type segment. The growth of high kits and reagents are driven by repeat purchase of kits and reagents as compared to instruments and increasing adoption of kit-based testing. Additionally, Services followed by High kits & reagents and Instruments will also boost the biologics safety testing market in coming years.
Moreover, growth in pharmaceutical and biotechnology industry, tremendous R&D ventures by new players in the life sciences industry, and increment in number of new medications launches in recent years drive the biologics safety testing market. However, stringent government directions for endorsement of biologics and high cost of medication advancement restricts the market development. Likewise, legislative aid towards giving assets to biologics advancement and its safety is predicted to offer lucrative market growth avenues. Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drugs entering into the market are few factors driving the biologics safety testing market. Regulatory organizations are working towards implementing relevant standards for biological safety to ensure the patient’s safety.
Among the regions, North America accounted for the largest share of the biologics safety testing market in 2020. Factors such as strong R&D trend in life sciences and growth in pharmaceutical industries will drive the biologics safety testing market in the North American region. The dominant share can be attributed to high investments in biotechnology, increased adoption in cancer research, and the development of new biologics, vaccines, & drugs.
SCOPE OF THE REPORT
Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing number of drug launches, high incidence and large economic burden of chronic diseases. In the coming years, emerging markets and increasing pharmaceutical outsourcing are expected to offer growth opportunities for players in the biologics safety testing market. The rising need for biologics has resulted in unprecedented growth in the number of biopharmaceutical companies. Increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve aspects of manufacturing processes such as productivity and cost-efficiency.
High kits and reagents accounted for the largest share of the market among product type segment. The growth of high kits and reagents are driven by repeat purchase of kits and reagents as compared to instruments and increasing adoption of kit-based testing. Additionally, Services followed by High kits & reagents and Instruments will also boost the biologics safety testing market in coming years.
Moreover, growth in pharmaceutical and biotechnology industry, tremendous R&D ventures by new players in the life sciences industry, and increment in number of new medications launches in recent years drive the biologics safety testing market. However, stringent government directions for endorsement of biologics and high cost of medication advancement restricts the market development. Likewise, legislative aid towards giving assets to biologics advancement and its safety is predicted to offer lucrative market growth avenues. Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drugs entering into the market are few factors driving the biologics safety testing market. Regulatory organizations are working towards implementing relevant standards for biological safety to ensure the patient’s safety.
Among the regions, North America accounted for the largest share of the biologics safety testing market in 2020. Factors such as strong R&D trend in life sciences and growth in pharmaceutical industries will drive the biologics safety testing market in the North American region. The dominant share can be attributed to high investments in biotechnology, increased adoption in cancer research, and the development of new biologics, vaccines, & drugs.
SCOPE OF THE REPORT
- The report analyses Biologics Safety Testing Market by Value.
- The report analyses Biologics Safety Testing Market Product Type (High Kits & Reagents, Instruments, Services).
- The report further assesses the Biologics Safety Testing Market by Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others).
- The report further assesses the Biologics Safety Testing Market by Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests and Others)
- The Global Nucleic Acid Isolation and Purification Market has been analysed By Region (North America, Europe, Asia Pacific and ROW) and By Country (United States, Canada, Germany, France, U.K, Italy, China, Japan, India and South Korea).
- The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, By Product, By Application, and By Test. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include Lonza Group Ltd., SGS S.A., Sartorious AG, Merck KGaA, Thermo Fisher Scientific Inc, Samsung Biologics, Charles River Laboratories International Inc., Maravai life sciences, Wuxi APPTEC, Eurofins Scientific.
- The report presents the analysis of Biologics Safety Testing Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
- Biologics Safety Testing suppliers
- Hospitals and healthcare units
- Consulting and Advisory Firms
- Investment Banks and Equity Firms
1. REPORT SCOPE AND METHODOLOGY
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. BIOLOGICS SAFETY TESTING MARKET: PRODUCT OVERVIEW
4. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SIZING AND FORECAST
4.1 Market Size, By Value, Year 2016-2026
4.2 Impact of COVID-19 on Biologics Safety Testing Market
5. GLOBAL BIOLOGICS SAFETY TESTING MARKET; AN ANALYSIS (2021-2026)
5.1 Competitive Scenario of Global Biologics Safety Testing Market: By Product
5.1.1 High Kits & Reagents ? Market Size and Forecast (2016-2026)
5.1.2 Instruments - Market Size and Forecast (2016-2026)
5.1.3 Services ? Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Biologics Safety Testing Market: By Application
5.2.1 Vaccine & Therapeutics ? Market Size and Forecast (2016-2026)
5.2.2 Blood & Blood Based Products ? Market Size and Forecast (2016-2026)
5.2.3 Gene Therapy - Market Size and Forecast (2016-2026)
5.2.4 Others ? Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Biologics safety testing Market: By Test
5.3.1 Endotoxin Tests - Market Size and Forecast (2016-2026)
5.3.2 Sterility Tests - Market Size and Forecast (2016-2026)
5.3.3 Bioburde Tests ?-Market Size and Forecast (2016-2026)
5.3.4 Adventitious Agent Detection Tests ? Market Size and Forecast (2016-2026)
5.3.5 Others ? Market Size and Forecast (2016-2026)
6. GLOBAL BIOLOGICS SAFETY TESTING MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Biologics safety testing Market: By Region
7. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
7.1 North America Biologics safety testing Market : Size and Forecast (2016-2026), By Value
7.2 North America Biologics safety testing Market ? Prominent Companies
7.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
7.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
7.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburde Tests, Adventitious Agent Detection Tests and Others)
7.6 North America Biologics safety testing Market: Country Analysis
7.7 Market Opportunity Chart of North America Biologics safety testing Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Biologics safety testing Market : By Country
7.9 United States Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.10 United States Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
7.11 Canada Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.12 Canada Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8. EUROPE BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
8.1 Europe Biologics safety testing Market : Size and Forecast (2016-2026), By Value
8.2 Europe Biologics safety testing Market ? Prominent Companies
8.3 Market Segmentation By Product Type (High Kits & Reagents, Instruments and Services)
8.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy, Others)
8.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests, Others)
8.6 Europe Biologics safety testing Market: Country Analysis
8.7 Market Opportunity Chart of Europe Biologics safety testing Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Biologics safety testing Market : By Country
8.9 Germany Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.10 Germany Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.11 United Kingdom Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.13 France Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.14 France Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.15 Italy Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.16 Italy Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9. ASIA PACIFIC BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
9.1 Asia Pacific Biologics safety testing Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Biologics safety testing Market ? Prominent Companies
9.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
9.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
9.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests and Others)
9.6 Asia Pacific Biologics safety testing Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Biologics safety testing Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Biologics safety testing Market : By Country
9.9 China Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.10 China Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.11 Japan Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.12 Japan Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.13 South Korea Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.14 South Korea Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.15 India Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.16 India Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
10. GLOBAL BIOLOGICS SAFETY TESTING MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Biologics safety testing Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Biologics safety testing Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Biologics safety testing Market - By Test, 2026
11.4 Market Attractiveness Chart of Global Biologics safety testing Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 SWOT Analysis
12.3 Market Share Analysis
13. REGULATORY COMPLIANCE
14. COMPANY PROFILES (BUSINESS DESCRIPTION, FINANCIAL ANALYSIS, BUSINESS STRATEGY)
14.1 Lonza Group Ltd.,
14.2 SGS S.A.
14.3 Sartorious AG
14.4 Merck KGaA
14.5 Thermo Fisher Scientific Inc.
14.6 Samsung Biologics,
14.7 Charles River Laboratories International Inc.
14.8 Maravai life sciences
14.9 Wuxi APPTEC
14.10 Eurofins Scientific
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. BIOLOGICS SAFETY TESTING MARKET: PRODUCT OVERVIEW
4. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SIZING AND FORECAST
4.1 Market Size, By Value, Year 2016-2026
4.2 Impact of COVID-19 on Biologics Safety Testing Market
5. GLOBAL BIOLOGICS SAFETY TESTING MARKET; AN ANALYSIS (2021-2026)
5.1 Competitive Scenario of Global Biologics Safety Testing Market: By Product
5.1.1 High Kits & Reagents ? Market Size and Forecast (2016-2026)
5.1.2 Instruments - Market Size and Forecast (2016-2026)
5.1.3 Services ? Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Biologics Safety Testing Market: By Application
5.2.1 Vaccine & Therapeutics ? Market Size and Forecast (2016-2026)
5.2.2 Blood & Blood Based Products ? Market Size and Forecast (2016-2026)
5.2.3 Gene Therapy - Market Size and Forecast (2016-2026)
5.2.4 Others ? Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Biologics safety testing Market: By Test
5.3.1 Endotoxin Tests - Market Size and Forecast (2016-2026)
5.3.2 Sterility Tests - Market Size and Forecast (2016-2026)
5.3.3 Bioburde Tests ?-Market Size and Forecast (2016-2026)
5.3.4 Adventitious Agent Detection Tests ? Market Size and Forecast (2016-2026)
5.3.5 Others ? Market Size and Forecast (2016-2026)
6. GLOBAL BIOLOGICS SAFETY TESTING MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Biologics safety testing Market: By Region
7. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
7.1 North America Biologics safety testing Market : Size and Forecast (2016-2026), By Value
7.2 North America Biologics safety testing Market ? Prominent Companies
7.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
7.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
7.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburde Tests, Adventitious Agent Detection Tests and Others)
7.6 North America Biologics safety testing Market: Country Analysis
7.7 Market Opportunity Chart of North America Biologics safety testing Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Biologics safety testing Market : By Country
7.9 United States Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.10 United States Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
7.11 Canada Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.12 Canada Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8. EUROPE BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
8.1 Europe Biologics safety testing Market : Size and Forecast (2016-2026), By Value
8.2 Europe Biologics safety testing Market ? Prominent Companies
8.3 Market Segmentation By Product Type (High Kits & Reagents, Instruments and Services)
8.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy, Others)
8.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests, Others)
8.6 Europe Biologics safety testing Market: Country Analysis
8.7 Market Opportunity Chart of Europe Biologics safety testing Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Biologics safety testing Market : By Country
8.9 Germany Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.10 Germany Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.11 United Kingdom Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.13 France Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.14 France Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.15 Italy Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.16 Italy Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9. ASIA PACIFIC BIOLOGICS SAFETY TESTING MARKET: AN ANALYSIS (2021-2026)
9.1 Asia Pacific Biologics safety testing Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Biologics safety testing Market ? Prominent Companies
9.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
9.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
9.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests and Others)
9.6 Asia Pacific Biologics safety testing Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Biologics safety testing Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Biologics safety testing Market : By Country
9.9 China Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.10 China Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.11 Japan Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.12 Japan Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.13 South Korea Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.14 South Korea Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.15 India Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.16 India Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
10. GLOBAL BIOLOGICS SAFETY TESTING MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Biologics safety testing Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Biologics safety testing Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Biologics safety testing Market - By Test, 2026
11.4 Market Attractiveness Chart of Global Biologics safety testing Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 SWOT Analysis
12.3 Market Share Analysis
13. REGULATORY COMPLIANCE
14. COMPANY PROFILES (BUSINESS DESCRIPTION, FINANCIAL ANALYSIS, BUSINESS STRATEGY)
14.1 Lonza Group Ltd.,
14.2 SGS S.A.
14.3 Sartorious AG
14.4 Merck KGaA
14.5 Thermo Fisher Scientific Inc.
14.6 Samsung Biologics,
14.7 Charles River Laboratories International Inc.
14.8 Maravai life sciences
14.9 Wuxi APPTEC
14.10 Eurofins Scientific
LIST OF FIGURES
Figure 1: Global Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Immunogenic Cell Death Inducers ? Mechanism of Action
Figure 3: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 4: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 5: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 6: Global Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 7: Source of Pipeline Innovation Shifting Increasingly Towards Biotech
Figure 8: Annual Biotech Funding Levels (In USD Billion)
Figure 9: Annual Biotech Funding Levels (In USD Billion)
Figure 10: Global Biologics Safety Testing Market- By Product Market Share, 2020 & 2026
Figure 11: Global Biologics Safety Testing Market- By Kits & Reagents, By Value (USD Million), 2016-2026
Figure 12: Global Biologics Safety Testing Market- By Instruments, By Value (USD Million), 2016-2026
Figure 13: Global Biologics Safety Testing Market- By Services, By Value (USD Million), 2016-2026
Figure 14: Global Biologics Safety Testing Market- By Application Market Share, 2020 & 2026
Figure 15: Global Biologics Safety Testing Market- By vaccine & Therapeutic, By Value (USD Million), 2016-2026
Figure 16: Global Biologics Safety Testing Market- By Blood & Blood Based Products, By Value (USD Million), 2016-2026
Figure 17: Global Biologics Safety Testing Market- By Gene Therapy, By Value (USD Million), 2016-2026
Figure 18: Global Biologics Safety Testing Market- By Others, By Value (USD Million), 2016-2026
Figure 19: Global Biology Safety Testing Market, By Application, 2020, 2026
Figure 20: Global Biologics Safety Testing Market- By Endotoxin Tests, By Value (USD Million), 2016-2026
Figure 21: Global Biologics Safety Testing Market- By Sterility Tests, By Value (USD Million), 2016-2026
Figure 22: Global Biologics Safety Testing Market- By Bioburden Tests, By Value (USD Million), 2016-2026
Figure 23: Global Biologics Safety Testing Market- By Adventitious Agent Detection Tests, By Value (USD Million), 2016-2026
Figure 24: Global Biologics Safety Testing Market- By Others, By Value (USD Million), 2016-2026
Figure 25: Global Biologics Safety Testing Market- By Region Market Share, 2020 & 2026
Figure 26: North America Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 27: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 28: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 29: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 30: North America Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 31: North America Biologics Safety Testing Market- By Product, By Value (USD Milion), 2016-2026
Figure 32: North America Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 33: North America Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 34: Market Opportunity Chart of Americas Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 35: North America Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 36: United States Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 37: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 38: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 39: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 40: United State Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 41: United States Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-202
Figure 42: United State Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 43: State Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 44: Canada Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 45: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 46: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 47: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 48: Canada Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 49: Canada Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 50: Canada Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 51: Canada Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 52: Europe Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 53: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 54: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 55: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 56: Europe Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 57: Europe Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 58: Europe Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 59: Europe Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 60: Market Opportunity Chart of Europe Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 61: Europe Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 62: Germany Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 63: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 64: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 65: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 66: Germany Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 67: Germany Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 68: Germany Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 69: Germany Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 70: United Kingdom Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 71: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 72: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 73: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 74: United Kingdom Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 75: United Kingdom Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 76: United Kingdom Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 77: United Kingdom Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 78: France Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 79: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 80: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 81: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 82: France Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 83: France Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 84: France Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 85: France Biologics Safety Testing Market- By test Type, By Value (USD Million), 2016-2026
Figure 86: Italy Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 87: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 88: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 89: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 90: Italy Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 91: Italy Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 92: Italy Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 93: Italy Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 94: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 95: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 96: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 97: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 98: Asia Pacific Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 99: Asia Pacific Biologics Safety Testing Market- By products, By Value (USD Million), 2016-2026
Figure 100: Asia Pacific Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 101: Asia Pacific Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 102: Market Opportunity Chart of APAC Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 103: APAC Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 104: China Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 105: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 106: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 107: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 108: China Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 109: China Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 110: China Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 111: China Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 112: Japan Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 113: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 114: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 115: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 116: Japan Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 117: Japan Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 118: Japan Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 119: Japan Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 120: South Korea Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 121: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 122: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 123: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 124: South Korea Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 125: South Korea Biologics Safety Testing Market- By products, By Value (USD Million), 2016-2026
Figure 126: South Korea Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 127: South Korea Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 128: India Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 129: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 130: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 131: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 132: India Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 133: India Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 134: India Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 135: India Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 136: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Product(Year-2026)
Figure 137: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Application(Year-2026)
Figure 138: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Test(Year-2026)
Figure 139: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Region (Year-2026)
Figure 140: Global Biologics Safety Testing company market share (%), 2019
Figure 141: Lonza Group AG Revenue, 2015-2019 (In USD Million)
Figure 142: Lonza Group AG Net Sales, By Geographical Region, 2019 (In %)
Figure 143: Lonza Group AG Net Sales, By Business Segment, 2019 (In %)
Figure 144: SGS S.A. Revenue, 2016-2020 (In USD Million)
Figure 145: SGS S.A. Net Sales, By Geographical Region, 2020 (In %)
Figure 146: SGS S.A. Net Sales, By Business Segment, 2020 (In %)
Figure 147: Sartorius AG Revenue, 2016-2020 (In USD Million)
Figure 148: Sartorius AG Net Sales, By Geographical Region, 2020 (In %)
Figure 149: Sartorius AG Net Sales, By Business Segment, 2020 (In %)
Figure 150: Merck KGaA Revenue, 2015-2019 (In USD Million)
Figure 151: Merck KGaA Net Sales, By Geographical Region, 2019 (In %)
Figure 152: Merck KGaA Net Sales, By Business Segment, 2019 (In %)
Figure 153: Thermo Fisher Scientific Inc. Revenue, 2015-2019 (In USD Million)
Figure 154: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2019 (In %)
Figure 155: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2019 (In %)
Figure 156: Samsung Biologics Revenue, 2016-2020 (In USD Million)
Figure 157: Samsung Biologics Net Sales, By Geographical Region, 2019 (In %)
Figure 158: Samsung Biologics Net Sales, By Business Segment, 2019 (In %)
Figure 159: Charles River Laboratories International Inc. Revenue, 2015-2019 (In USD Million)
Figure 160: Charles River Laboratories International Inc. Net Sales, By Geographical Region, 2019 (In %)
Figure 161: Charles River Laboratories International Inc. Net Sales, By Business Segment, 2019 (In %)
Figure 162: Maravai Biologics Safety Revenue, 2016-2020 (In USD Million
Figure 163: Maravai Life Sciences Biologics Safety Net Sales, By Geographical Region, 2019 (In %)
Figure 164: Maravai Life Sciences Biologics Safety Net Sales, By Business Segment, 2020 (In %)
Figure 165: Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
Figure 166: Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)
Figure 167: Eurofins Scientific Revenue, 2015-2019 (In USD Million)
Figure 168: Eurofins Scientific Net Sales, By Geographical Region, 2019 (In %)
Figure 1: Global Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Immunogenic Cell Death Inducers ? Mechanism of Action
Figure 3: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 4: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 5: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 6: Global Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 7: Source of Pipeline Innovation Shifting Increasingly Towards Biotech
Figure 8: Annual Biotech Funding Levels (In USD Billion)
Figure 9: Annual Biotech Funding Levels (In USD Billion)
Figure 10: Global Biologics Safety Testing Market- By Product Market Share, 2020 & 2026
Figure 11: Global Biologics Safety Testing Market- By Kits & Reagents, By Value (USD Million), 2016-2026
Figure 12: Global Biologics Safety Testing Market- By Instruments, By Value (USD Million), 2016-2026
Figure 13: Global Biologics Safety Testing Market- By Services, By Value (USD Million), 2016-2026
Figure 14: Global Biologics Safety Testing Market- By Application Market Share, 2020 & 2026
Figure 15: Global Biologics Safety Testing Market- By vaccine & Therapeutic, By Value (USD Million), 2016-2026
Figure 16: Global Biologics Safety Testing Market- By Blood & Blood Based Products, By Value (USD Million), 2016-2026
Figure 17: Global Biologics Safety Testing Market- By Gene Therapy, By Value (USD Million), 2016-2026
Figure 18: Global Biologics Safety Testing Market- By Others, By Value (USD Million), 2016-2026
Figure 19: Global Biology Safety Testing Market, By Application, 2020, 2026
Figure 20: Global Biologics Safety Testing Market- By Endotoxin Tests, By Value (USD Million), 2016-2026
Figure 21: Global Biologics Safety Testing Market- By Sterility Tests, By Value (USD Million), 2016-2026
Figure 22: Global Biologics Safety Testing Market- By Bioburden Tests, By Value (USD Million), 2016-2026
Figure 23: Global Biologics Safety Testing Market- By Adventitious Agent Detection Tests, By Value (USD Million), 2016-2026
Figure 24: Global Biologics Safety Testing Market- By Others, By Value (USD Million), 2016-2026
Figure 25: Global Biologics Safety Testing Market- By Region Market Share, 2020 & 2026
Figure 26: North America Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 27: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 28: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 29: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 30: North America Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 31: North America Biologics Safety Testing Market- By Product, By Value (USD Milion), 2016-2026
Figure 32: North America Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 33: North America Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 34: Market Opportunity Chart of Americas Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 35: North America Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 36: United States Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 37: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 38: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 39: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 40: United State Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 41: United States Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-202
Figure 42: United State Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 43: State Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 44: Canada Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 45: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 46: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 47: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 48: Canada Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 49: Canada Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 50: Canada Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 51: Canada Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 52: Europe Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 53: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 54: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 55: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 56: Europe Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 57: Europe Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 58: Europe Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 59: Europe Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 60: Market Opportunity Chart of Europe Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 61: Europe Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 62: Germany Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 63: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 64: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 65: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 66: Germany Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 67: Germany Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 68: Germany Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 69: Germany Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 70: United Kingdom Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 71: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 72: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 73: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 74: United Kingdom Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 75: United Kingdom Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 76: United Kingdom Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 77: United Kingdom Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 78: France Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 79: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 80: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 81: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 82: France Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 83: France Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 84: France Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 85: France Biologics Safety Testing Market- By test Type, By Value (USD Million), 2016-2026
Figure 86: Italy Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 87: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 88: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 89: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 90: Italy Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 91: Italy Biologics Safety Testing Market- By Products, By Value (USD Million), 2016-2026
Figure 92: Italy Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 93: Italy Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 94: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 95: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 96: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 97: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 98: Asia Pacific Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 99: Asia Pacific Biologics Safety Testing Market- By products, By Value (USD Million), 2016-2026
Figure 100: Asia Pacific Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 101: Asia Pacific Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 102: Market Opportunity Chart of APAC Biologics Safety Testing Market- By Country, By Value (Year-2026)
Figure 103: APAC Biologics Safety Testing Market- By Country Market Share, 2020 & 2026
Figure 104: China Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 105: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 106: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 107: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 108: China Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 109: China Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 110: China Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 111: China Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 112: Japan Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 113: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 114: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 115: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 116: Japan Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 117: Japan Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 118: Japan Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 119: Japan Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 120: South Korea Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 121: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 122: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 123: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 124: South Korea Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 125: South Korea Biologics Safety Testing Market- By products, By Value (USD Million), 2016-2026
Figure 126: South Korea Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 127: South Korea Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 128: India Biologics Safety Testing Market Size, By Value, 2016-2026 (USD Million)
Figure 129: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 130: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 131: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 132: India Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 133: India Biologics Safety Testing Market- By Product, By Value (USD Million), 2016-2026
Figure 134: India Biologics Safety Testing Market- By Application, By Value (USD Million), 2016-2026
Figure 135: India Biologics Safety Testing Market- By Test Type, By Value (USD Million), 2016-2026
Figure 136: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Product(Year-2026)
Figure 137: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Application(Year-2026)
Figure 138: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Test(Year-2026)
Figure 139: Market Attractiveness Chart of Global Biologics Safety Testing Market- By Region (Year-2026)
Figure 140: Global Biologics Safety Testing company market share (%), 2019
Figure 141: Lonza Group AG Revenue, 2015-2019 (In USD Million)
Figure 142: Lonza Group AG Net Sales, By Geographical Region, 2019 (In %)
Figure 143: Lonza Group AG Net Sales, By Business Segment, 2019 (In %)
Figure 144: SGS S.A. Revenue, 2016-2020 (In USD Million)
Figure 145: SGS S.A. Net Sales, By Geographical Region, 2020 (In %)
Figure 146: SGS S.A. Net Sales, By Business Segment, 2020 (In %)
Figure 147: Sartorius AG Revenue, 2016-2020 (In USD Million)
Figure 148: Sartorius AG Net Sales, By Geographical Region, 2020 (In %)
Figure 149: Sartorius AG Net Sales, By Business Segment, 2020 (In %)
Figure 150: Merck KGaA Revenue, 2015-2019 (In USD Million)
Figure 151: Merck KGaA Net Sales, By Geographical Region, 2019 (In %)
Figure 152: Merck KGaA Net Sales, By Business Segment, 2019 (In %)
Figure 153: Thermo Fisher Scientific Inc. Revenue, 2015-2019 (In USD Million)
Figure 154: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2019 (In %)
Figure 155: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2019 (In %)
Figure 156: Samsung Biologics Revenue, 2016-2020 (In USD Million)
Figure 157: Samsung Biologics Net Sales, By Geographical Region, 2019 (In %)
Figure 158: Samsung Biologics Net Sales, By Business Segment, 2019 (In %)
Figure 159: Charles River Laboratories International Inc. Revenue, 2015-2019 (In USD Million)
Figure 160: Charles River Laboratories International Inc. Net Sales, By Geographical Region, 2019 (In %)
Figure 161: Charles River Laboratories International Inc. Net Sales, By Business Segment, 2019 (In %)
Figure 162: Maravai Biologics Safety Revenue, 2016-2020 (In USD Million
Figure 163: Maravai Life Sciences Biologics Safety Net Sales, By Geographical Region, 2019 (In %)
Figure 164: Maravai Life Sciences Biologics Safety Net Sales, By Business Segment, 2020 (In %)
Figure 165: Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
Figure 166: Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)
Figure 167: Eurofins Scientific Revenue, 2015-2019 (In USD Million)
Figure 168: Eurofins Scientific Net Sales, By Geographical Region, 2019 (In %)
